Under the agreement, the company with Mylan Pharma will market and sell two brands Ativan and Pacitane. The contract is for ...
The weight-loss drug market is heating up, with Swiss company Roche making a bold move by acquiring Carmot Therapeutics for up to $3.1 billion in 2023. This investment is aimed at accelerating its ...
These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.
Chuck Hardwick, the Kentucky-born son of a Wonder Bread maintenance worker who became a significant force in New Jersey ...
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Pfizer CEO Dr. Albert Bourla was loudly booed during a White House Black History Month event where he was introduced by President Trump.
PFE offers a 6.73% dividend yield and growth potential, driven by strategic acquisitions, R&D, and discounted valuations.
While smokable product sales are declining slowly, sales of non-smokable products are driving growth for Altria Group. The ...
Pfizer Inc. (NYSE:PFE – Get Free Report) was the target of some unusual options trading activity on Friday. Stock traders ...
Trump Ignites Controversy at Black History Month Event** Amidst the backdrop of a politically charged climate, President Donald Trump recently found himself i ...